MARK1 Antikörper (Internal Region)
Kurzübersicht für MARK1 Antikörper (Internal Region) (ABIN238668)
Target
Alle MARK1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Bindungsspezifität
- Internal Region
-
Verwendungszweck
- Mark1 (mouse)
-
Sequenz
- EQKEEWDKDT ARR
-
Kreuzreaktivität
- Maus, Ratte
-
Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Immunogen
- Peptide with sequence C-EQKEEWDKDTARR, from the internal region of the protein sequence according to NP_663490.1.
-
Isotyp
- IgG
-
-
anti-MAP/microtubule Affinity-Regulating Kinase 1 (MARK1) (AA 560-700) antibody
MARK1 Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-MAP/microtubule Affinity-Regulating Kinase 1 (MARK1) (AA 6-40), (N-Term) antibodyMARK1 Reaktivität: Human, Maus WB, IHC (p) Wirt: Kaninchen Polyclonal RB8545 unconjugated
anti-MAP/microtubule Affinity-Regulating Kinase 1 (MARK1) (AA 643-674), (C-Term) antibodyMARK1 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB1272 unconjugated
anti-MAP/microtubule Affinity-Regulating Kinase 1 (MARK1) (AA 671-700), (C-Term) antibodyMARK1 Reaktivität: Human, Maus WB Wirt: Kaninchen Polyclonal RB8547 unconjugated
anti-MAP/microtubule Affinity-Regulating Kinase 1 (MARK1) (Internal Region) antibodyMARK1 Reaktivität: Human, Affe, Kaninchen, Fledermaus IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-MAP/microtubule Affinity-Regulating Kinase 1 (MARK1) (N-Term) antibodyMARK1 Reaktivität: Human, Affe, Kaninchen, Pferd IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-MAP/microtubule Affinity-Regulating Kinase 1 (MARK1) (N-Term) antibodyMARK1 Reaktivität: Human, Affe, Kaninchen, Fledermaus, Rind (Kuh), Hund IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-MAP/microtubule Affinity-Regulating Kinase 1 (MARK1) (Center) antibodyMARK1 Reaktivität: Human, Maus, Ratte, Zebrafisch (Danio rerio) WB, IHC, IF, IC Wirt: Kaninchen Polyclonal unconjugated
anti-MAP/microtubule Affinity-Regulating Kinase 1 (MARK1) (AA 6-40) antibodyMARK1 Reaktivität: Human, Maus WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-MAP/microtubule Affinity-Regulating Kinase 1 (MARK1) antibodyMARK1 Reaktivität: Human, Maus, Ratte WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
-
Western Blot: Preliminary experiments in Brain and Testis lysates from Mouse and Rat gave no specific signal but low background (at antibody concentration up to 1 μg/mL). We would appreciate any feedback from people in the field - have any results been re
Peptide ELISA: antibody detection limit dilution 1:1000.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Minimize freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- MARK1 (MAP/microtubule Affinity-Regulating Kinase 1 (MARK1))
-
Andere Bezeichnung
- MARK1
-
Hintergrund
- Mark1, MAP/microtubule affinity-regulating kinase 1, AW491150, B930025N23Rik, Emk3, KIAA1477, mKIAA1477
-
Gen-ID
- 226778, 117016
-
NCBI Accession
- NP_663490
-
Pathways
- SARS-CoV-2 Protein Interaktom, Phosphorylierungen bei SARS-CoV-2 Infektion
Target
-
